Trial Profile
Long-Term Follow-Up Study of Recipients of Gene Transfer Research Protocols
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2022
Price :
$35
*
At a glance
- Drugs Anti-CD19 CAR-transduced T cells (Primary)
- Indications Lymphoid leukaemia; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacogenomic
- 22 Aug 2022 Planned End Date changed from 1 Dec 2027 to 31 Dec 2027.
- 22 Aug 2022 Planned primary completion date changed from 1 Dec 2026 to 31 Dec 2026.
- 12 Jan 2020 Results published in the Blood.